Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response

In clinical trials, metronomic cyclophosphamide (CPA) is increasingly being combined with vaccines to reduce tumor-induced immune suppression. Previous strategies to modulate the immune system during vaccination have involved continuous administration of low dose chemotherapy, studies that have pose...

Descripción completa

Detalles Bibliográficos
Autores principales: Weir, Genevieve M, Hrytsenko, Olga, Stanford, Marianne M, Berinstein, Neil L, Karkada, Mohan, Liwski, Robert S, Mansour, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368141/
https://www.ncbi.nlm.nih.gov/pubmed/25960932
http://dx.doi.org/10.4161/21624011.2014.953407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368141/
https://www.ncbi.nlm.nih.gov/pubmed/25960932
http://dx.doi.org/10.4161/21624011.2014.953407

Ejemplares similares